Colonial River Investments, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1845859
MIDLOTHIAN, VA
Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$277,475
-$111,162 QoQ
Shares Held
445
-11.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#960
of 1,320 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Colonial River Investments, LLC holds $898,200 across 2 Biotechnology names. REGN ranks #2 (30.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
4,658 | $620,725 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
445 | $277,475 |
All Filings in REGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,475 | 445 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $388,637 | 503 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $379,760 | 492 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $272,138 | 484 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $235,200 | 448 | Shares | Sole | 2025-07-15 | |
| 2023-03-31 | $270,329 | 329 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $246,028 | 341 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $224,571 | 326 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||